Giant cell arteritis as a cause of first-ever stroke
Malgorzata Wiszniewska1, Gerald Devuyst, Julien Bogousslavsky
1Department of Neurology CHUV, Lausanne, Switzerland. mpwisz@pi.onet.pl
Insights
Giant cell arteritis (GCA) rarely causes stroke, affecting 0.15% of patients. Early treatment with antiplatelet drugs and corticosteroids may prevent this dangerous complication.
Area of Science:
- Rheumatology
- Neurology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis.
- Stroke is a potential neurological complication of GCA.
Observation:
- This study investigated the frequency and characteristics of stroke in GCA patients.
- Six patients (0.15%) in the Lausanne Stroke Registry had GCA and stroke.
- Stroke occurred within 0-2 months of GCA diagnosis, often accompanied by headache.
Findings:
- Cerebral ischemia patterns included lacunar and territorial infarcts.
- Histologically proven temporal arteritis was confirmed in all affected patients.
- Risk factors, patterns, latency, and therapy were analyzed in GCA-stroke patients.
Implications:
- Stroke is a rare but serious complication of GCA.
- Combined antiplatelet and corticosteroid therapy may be beneficial for stroke prevention in GCA.
- Increased awareness and prompt management are crucial for GCA patients at risk of stroke.
Abstract:
The aims of this study were to assess how frequently giant cell arteritis (GCA) was a cause of first-ever stroke in 4,086 patients in the Lausanne Stroke Registry and to determine the risk factors, patterns, latency and current therapy at onset in patients with GCA plus stroke. GCA was recognized using the criteria of the American College of Rheumatology. We report on 6 patients (0.15%) with a histologically proven diagnosis of temporal arteritis and clinical and neuroradiological evidence of cerebral ischemia. The CT and MRI scans showed lacunar infarction in 3 patients, territorial infarction in 2 and were normal in 1. Stroke latency ranged from 0 to 2 months. All patients suffered from headache. We conclude that stroke is a rare, but dangerous, complication of GCA and that a combination of antiplatelet drugs and corticosteroids may be advisable for preventing stroke occurrence.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Ischemic Stroke l: Introduction
Stroke: Introduction and Types

